Galderma
CLICK HERE if you are a Healthcare Professional
Roll Over for Important Safety Information

MEDICAL OR PERSONAL HEALTH QUESTIONS

Please contact your physician or healthcare provider. We cannot respond to questions about general medical information or questions regarding a specific condition.

If you have had an adverse experience while using our product, or the product does not appear to meet appropriate quality standards, please call 1-866-735-4137. You are also encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

General Product Questions
Please call 1-866-735-4137 or email us at Metrobrands.us@galderma.com and we will respond on a first-come, first-served basis. Due to the number of questions we receive, we cannot respond to everyone, nor can we answer each question individually.

If you wish to contact us via postal mail, our mailing address is:

Galderma Laboratories
Attn: Brand Manager, MetroGel® 1%
14501 North Freeway.
Fort Worth, TX 76177
USA


IMPORTANT SAFETY INFORMATION

METROGEL® (metronidazole) Gel, 1% is indicated for the topical treatment of inflammatory lesions of rosacea. The most common adverse reactions that have been reported with the topical use of METROGEL® 1% are sore throat/nasal congestion, upper respiratory tract infections, and headaches, as well as dryness, scaling, itching, and stinging. Transient redness, metallic taste, tingling or numbness of extremities and nausea have also been reported with the topical use of metronidazole. Tell your doctor if you are using blood thinning drugs like coumarin or warfarin, because there is a risk of interaction with metronidazole. Do not use METROGEL® 1% if you are allergic to metronidazole or any of the other ingredients in the gel. METROGEL® 1% is available by prescription only. Talk to your doctor to learn more about METROGEL® 1%.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.